Insmed (INSM) Interest & Investment Income (2010 - 2026)
Insmed (INSM) recorded quarterly Interest & Investment Income of $12.0 million in Q1 2026, down 20.98% quarter-over-quarter from $15.2 million in Q4 2025, and down 13.42% on a YoY basis from $13.9 million in Q1 2025.
Insmed (INSM) Interest & Investment Income (2010 - 2026) Analysis & Trends
Insmed's Interest & Investment Income history runs 17 years deep, the most recent figure standing at $12.0 million for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 13.42% year-over-year to $12.0 million; the TTM figure through Mar 2026 stood at $58.8 million (up 0.62% YoY), while the FY2025 annual figure was $60.7 million, up 13.79% from the prior year.
- Interest & Investment Income was $12.0 million for Q1 2026 at Insmed, down from $15.2 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $18.3 million in Q3 2025 to a low of $137000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $10.5 million across 5 years, with a median of $10.6 million in 2023.
- The sharpest annual moves came in 2022 and 2024: Interest & Investment Income soared 13536.07% in 2022, then retreated 16.54% in 2024.
- A 5-year view of Interest & Investment Income shows it stood at $8.3 million in 2022, then gained by 18.45% to $9.9 million in 2023, then surged by 75.14% to $17.3 million in 2024, then decreased by 11.71% to $15.2 million in 2025, then slipped by 20.98% to $12.0 million in 2026.
- The last three Interest & Investment Income figures came in at $12.0 million (Q1 2026), $15.2 million (Q4 2025), and $18.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -14.79 Mn |
| 10 | Insmed | 19.79 Bn | 18.57 Bn | 258.54 Mn | 12.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.04 Mn |
| Dec 31, 2025 | 15.24 Mn |
| Sep 30, 2025 | 18.29 Mn |
| Jun 30, 2025 | 13.23 Mn |
| Mar 31, 2025 | 13.91 Mn |
| Dec 31, 2024 | 17.26 Mn |
| Sep 30, 2024 | 16.98 Mn |
| Jun 30, 2024 | 10.29 Mn |
| Mar 31, 2024 | 8.78 Mn |
| Dec 31, 2023 | 9.85 Mn |
| Sep 30, 2023 | 10.58 Mn |
| Jun 30, 2023 | 11.17 Mn |
| Mar 31, 2023 | 10.52 Mn |
| Dec 31, 2022 | 8.32 Mn |
| Sep 30, 2022 | 1.79 Mn |
| Jun 30, 2022 | 835,000.00 |
| Mar 31, 2022 | 137,000.00 |
| Dec 31, 2021 | 61,000.00 |
| Sep 30, 2021 | 46,000.00 |
| Jun 30, 2021 | 34,000.00 |